Introduction
The potential danger of ethylene oxide (EtO*) to human health has been discussed for several years. Although its mutagenic action has been known for a long time (1), it was not until 1967, when cytogenetic studies of workers occupationally exposed to EtO were published that serious attention was paid to its potential cancer risk (2) .
The toxicological interest in EtO is based, first of all, on the fact that this chemical, the simplest member of the class of epoxides, is widely used in the chemical industry. The consumption of EtO in Western Europe is ~2.5 x 10* tons per year, the USA annually produces ~ 800 000 tons and ~ 150 000 workers deal with it daily in different industrial processes (3) . Examples of industrial processes include the production of ethylene glycol (antifreeze), as well as of synthetic fibers, films, detergents, etc. The sterilization of heat-sensitive medical materials by EtO is another important field of use for this chemical. Since EtO at room temperature is a colorless and odorless (below 700 p.p.m.) gas it is likely that those dealing with sterilization would inhale it.
Furthermore, EtO is an alkylating agent, which may react directly with nucleophilic macromolecules (such as DNA, RNA and proteins) without requiring metabolic activation. The ability of EtO to alkylate (hydroxyethylate) DNA (4) and to introduce alkylations in haemoglobin (5) has been demonstrated. EtO may be considered as a model substance for the whole class of epoxides for studies of DNA and protein damage and for DNA repair mechanisms.
Since EtO is produced metabolically by soil microorganisms from ethylene and by combustion of organic compounds, it is an environmental carcinogen. Moreover, ethylene is present as a pollutant in urban air and as a component of cigarette smoke. The inhalation of ethylene in animals results in exhalation of EtO (6, 7) .
The genetic effects of epoxides, including EtO, and the problems connected with the risk estimation of epoxides have been reviewed by Ehrenberg and Hussain (8) . Several recent reviews have summarized the toxicological and epidemiological data (9) (10) (11) (12) . In our review we will up-date the present knowledge with the emphasis on carcinogenic and genotoxic effects of EtO in experimental animals and occupationally exposed persons.
Observations in experimental animals exposed to EtO
The most significant biological effects of EtO and their frequencies (in animals) are summarized in Table I . Long-term intragastric administration resulted in tumours of the forestomach, but not of the glandular stomach (13) . The author explained this dif-"Abbreviations: EtO, ethylene oxide; SCE, sister chromatid exchange; UDS, unscheduled DNA synthesis.
ference by a protective action of acidic juice on the stomach epithelium.
The majority of authors have administered EtO by inhalation in their studies. It is interesting to note that in most cases lung cancers or disorders of the respiratory tract were not observed. However, peritoneal mesotheliomas, mononuclear cell leukaemias and brain tumours were found. The frequency of a very rare type of brain tumour, glioma, which occurs spontaneously in rats, was significantly increased at 100 p.p.m. of EtO (3) .
Besides the induction of tumours, other genetic and toxic effects have been observed after prolonged EtO treatment. An increased level of chromatid-type aberrations and sister chromatid exchanges (SCE) were observed in rats after a short-term exposure (21) , as well as after long-term exposure (20, 22) in rabbits and monkeys.
Inhalation of EtO has also induced heritable reciprocal translocations in mice (16) and enhanced the dominant lethal mutation frequency in mice and rats (17, 19) . However, the spermatogonial stem-cell mutation rate (18) was not significantly increased.
Neurotoxic disorders (neuropathy) were described in rats exposed to EtO by inhalation (25) .
Some authors have observed an increase in mortality and decrease of body weight in experimental animals as a consequence of chronic inhalation, and also observed effects on reproduction (Table I) .
Experimental animals can be used as an appropriate model for die study of the degree of alkylation in DNA and in haemoglobin (26) . Experiments in vivo with radiolabelled ethene and EtO (administered to mice by inhalation and by injection, respectively) demonstrated the production of N-7-hydroxyethylguanine in DNA, and hydroxyethylated valine, cysteine and histidine in haemoglobin (4, 27) . The haemoglobin alkylation values may be used for the calculation of EtO doses in vivo and for the evaluation of the risk in man (28) . This approach can also be used for measuring the haemoglobin alkylation level in employees occupationally exposed to alkylating agents (29, 30) .
Carcinogenic effects in humans
There are several reasons why it is difficult to give a definite answer concerning the carcinogenicity of EtO in humans: (i) the restricted number of available epidemiological studies; (ii) the available epidemiological studies are based on too small samples of the studied persons; (iii) difficulties in separating EtO exposure from exposures to other chemicals; (iv) insufficient knowledge concerning exposure doses; (v) the absence of an obvious effect of EtO in some studies. In spite of this, many investigators have analyzed the available data (11, 12, 33) and concluded that EtO is carcinogenic in man. The recent data from different investigations of exposed persons and observed effects (if available) are summarized in Table II .
Epidemiological studies of cancer incidence and mortality with the intention of analyzing the consequences of EtO exposure in A.Kolman, M.NHslund and CJ.CaUeman 
humans have been undertaken in Sweden (31 -33) and in the USA (34) . In the first epidemiological study (1968 -1977) 
from the Swedish national statistical evaluation of leukaemia incidence (32, 33) . In another study of 89 workers dealing with production of EtO and employed for a minimum of 1 year (years 1961 -1977), with 10 years latency time after the first exposure, the increase in mortality was recorded: 23 deaths against 13.5 expected (P < 0.05) (33) . The increase in cancer incidence was also registered: 9 cases against 3.4 expected (P < 0.01). Among the cancer cases were cases of stomach cancer, chronic lymphatic leukaemia and acute myeloid leukaemia. The higher mortality was also due to circulatory system diseases: 12 cases against 6.3 expected. The same group of 89 workers was followed up until 1982, and one additional case of acute blast leukaemia was registered among the exposed women. Altogether, during the period 1968 -1982 the cancer incidence in this group of workers increased twice, and the incidence of leukaemia increased 13.3 times (33) . Two groups of workers served as controls in this study: one employed in the chemical industry (66 persons), the second, workers exposed to low-intermittent doses of EtO (86 persons). In both control groups no significant increase in mortality or cancer incidence was observed.
Different conclusions were drawn from the epidemiological study of workers occupied in EtO production in Texaco Chemical Company plant, USA, during 1955 -1977 (34) : no increases, compared with the US average, were found in mortality and incidence of leukaemia: 46 deaths against 80 expected and 0 cases of leukaemia against 0.7 expected were reported. An increase in frequency of pancreatic cancer (3 cases against 0.8 expected), bladder cancer (1/0.31) and brain cancer (2/0.7) was considered as statistically non-significant.
It cannot be excluded that the absence of an EtO effect in this study depends on the improved technical conditions of EtO production since all operations are performed in a closed system and mostly out-doors, and the contact of the workers with EtO was minimal. Although other epidemiological studies concerned with cancer incidence are not at our disposal, nevertheless the available data (33) already confirm an increased risk related to EtO. Therefore new, long-term epidemiological investigations in large populations are needed especially in the European countries where EtO is widely used for sterilization in hospitals (as for example in France and West Germany).
Other health disorders in humans
Besides the above-mentioned studies concerning mortality and cancer incidence, several authors have reported other consequences of EtO exposure. For example, the increased frequencies of spontaneous abortions in personnel working with sterilization of medical instruments in Finnish hospitals during the year 1980 was demonstrated by Hemminki et al. (35) . The rate of spontaneous abortions in persons dealing with EtO during pregnancy increased ~ 3 times in comparison with nursing auxiliaries, who served as a control group.
The neurological disorders (polyneuropathy) in workers exposed occasionally to high EtO doses (up to 700 p.p.m.) were also described in several investigations (46 -48) . The electron microscopic observations of the nerve fibres of a steriliser worker with a peripheral neuropathy (exposed few times daily to high EtO levels, up to 500 p.p.m., during a period of 5 months) showed a degeneration of myelin which was partly reversed after the cessation of EtO exposure (48) .
Among other health disorders recently described in the literature was an increase in proteinurea reported in workers exposed to low EtO doses (49) , although the biological significance of this observation and its connection to other clinical symptoms have not yet been explained. Skin irritation (50) and cataract formation in the internal eye (51) were also observed at high exposure levels (1000 and 700 p.p.m., respectively).
Cytological studies in exposed persons
Many authors have chosen for their cytological studies chromosomal aberrations and SCE in peripheral blood lymphocytes (Table U) . There are many indications concerning a relationship between chromosomal aberrations and carcinogenesis in eukaryotic cells (52) . Patients with higher spontaneous levels of chromosomal aberrations develop malignancies more easily and belong to a higher risk group (53) . The relationship of particular chromosomal aberrations with specific types of leukaemia and lymphoma has been described (54) .
Accidental exposure of workers to a high EtO concentration (~ 1500 p.p.m.) has resulted in a significant increase (5.4 times) in chromosomal aberrations in peripheral blood lymphocytes (2) . The ability of EtO to induce chromosomal aberrations in humans also at low doses of exposure has also been reported (36 -38) .
EtO can also effectively induce chromosomal aberrations in a human amniotic cell line in vitro (55) . Such chromosomal aberrations are similar to those induced by other alkylating agents (56) and belong to the chromatid type (gaps, breaks and different types of exchanges).
Exposure to genotoxic chemicals and cigarette smoking is associated with an increase in SCE frequency in humans (57) . Several authors have studied the ability of EtO to induce SCE in peripheral blood lymphocytes in exposed workers. A statistically significant increase in the SCE frequency was registered also at low exposure levels in steriliser workers (40, 42) and in laboratory personnel (43) . However, Hansen et al. (44) did not find any significant increase in the SCE frequency in steriliser workers who had been exposed to EtO concentrations lower than 5 p.p.m. compared with a control group.
A dose -response relationship of induced SCE levels at higher (cumulative) EtO doses has been demonstrated in the exposed plant and steriliser workers (58, 39, 41) . According to these authors, increased SCE frequencies can persist in observed persons even after cessation of work with EtO.
In another study, Van Sittert et al. (45) did not find any significant increase in SCE frequencies in peripheral blood lymphocytes of plant workers exposed to low levels of EtO (mostly below 0.05 p.p.m., with a maximum level of 8 p.p.m.). The absence of statistically significant effects at low exposure levels can probably be explained by repair processes in human lymphocytes (see the section 'EtO and DNA repair'). The same authors also measured the amount of alkylation in haemoglobin of exposed and control persons and did not find any statistically significant difference.
The interaction of tobacco smoking and EtO exposure
The data concerning cigarette smoking and its interaction with damage produced by EtO are contradictory. Hemminki et al. (35) did not find any additional effects of smoking on the frequency of spontaneous abortion in personnel working with sterilization in hospitals. However, a significant effect of smoking on the frequency of micronuclei in erythroblasts and lymphocytes of exposed workers was found in another study (37) .
The influence of smoking on SCE induction in persons exposed to EtO was reviewed by Laurent et al. (39) . Some authors have found a correlation between cigarette smoking and SCE induction by EtO exposure (43,40) whereas others did not observe any significant difference between smokers and non-smokers (39, 58, 59 ).
Induction of point mutation by EtO
The ability of EtO to induce point mutations in bacteria and mammalian cells has been reviewed earlier by Ehrenberg and Hussain (8) . EtO is an effective inducer of forward mutations in the lad gene of Escherichia coli as well as back mutations in auxotrophic E. coli strains (60) . The mutagenic action of EtO in Schizosaccharomyces pombe has been also described (61) . EtO induced dominant lethal mutations in male mice when administered as a single i.p. injection or by inhalation (17) .
EtO and DNA repair
Interaction of alkylating agents with DNA leads to the formation of different modified bases (adducts). Even a very low level of adducts (one modified base per 10 5 -10 6 nucleotides) can be tumorigenic in experimental animals treated with alkylating chemicals (62) . Alkylated bases may be released from DNA with the help of several repair enzymes, as described recently in both bacteria and mammalian cells (63, 64) . The first group of these enzymes, N-glycosylases, cleave base -sugar bonds and remove alkylated purine residues. The second group includes alkyltransferases which can move the alkyl group from O'-alkylguanine to an acceptor sulfhydryl group on a cysteine residue. Release of modified bases from DNA also lead to generation of apurinic/ apyrimidinic sites which can be easily attacked by AP endonuclease and give rise to strand breaks.
It was supposed that similar mechanisms participate in the repair of methylated and ethylated DNA (reviewed by Teebor and Frenkel, 64) . However, it is known from experiments in bacteria that the ethyl group is removed from DNA more slowly than the methyl group (65, 66) .
Bacteria possess repair mechanisms which can participate in the elimination of DNA damage induced by EtO (60, 67) . From the experiments with bacterial strains with different repair capacities (Lac-strains of E. coll) it was concluded that excision repair is essential when cells have been treated with EtO. It was also shown that adaptive response (68) acts in bacteria treated with EtO and can considerably decrease the mutagenic response and increase survival (69) .
Our present knowledge of the mechanisms involved in DNA repair of EtO damage in mammalian cells is incomplete. Pero et al. (70) have shown that EtO inhibited unscheduled DNA synthesis (UDS) in lymphocytes of workers occupationally exposed to low levels of EtO (0.5 -1 p.p.m.). UDS is characteristic for enzymatic repair of damaged DNA and its inhibition may be related to increased risk connected with the exposure to genotoxic agents.
The analysis of SCE in human peripheral blood lymphocytes treated by EtO in vitro have shown that SCE frequencies were significantly decreased after 18 h of post-treatment incubation (71) . From this observation the authors suggested that EtO damage to DNA was rapidly recognized and a significant part of the lesions could be repaired.
Conclusions: The assessment of cancer risks in humans
The Swedish epidemiological data and experimental data with exposed animals indicate that EtO should be considered a carcinogenic chemical. Its other genotoxic and health-damaging effects have been described elsewhere. It is important, therefore, that the EtO exposure in workplaces should be minimized. According to the recommendations of the US National Institute for Occupational Safety and Health (NTOSH) the EtO exposure level should be reduced to 0.1 p.p.m. 8 h time-weighted average (9) . The highest level allowed in Sweden (1982) is 5 p.p.m., in other Western European countries it varies between 5 and 50 p.p.m.
Chemical damage to DNA produced by EtO can lead to gene mutation and/or cancer. DNA alkylation occurs even at the lowest doses and may lead to induction of mutations. The doseresponse curves for the induction of point mutation and prophage in bacteria by EtO have a linear character at low and low -intermediate doses and indicate a one-hit mechanism (8, 72, 73) . An extrapolation has shown that, at very low doses, dose -response curves retain their linear shape and have no thresholds (73, 74) .
During the past decade methods have been developed for the determination of alkylation products between alkylating agents and bases in the DNA and nucleophilic amino acids in proteins, notably haemoglobin (75) . Determination of alkylation products in the haemoglobin of workers occupationally exposed to EtO have been used for the computation of in vivo doses resulting from human EtO exposure (29) . For the risk estimation of human exposure to alkylating agents, such as for example EtO, Ehrenberg has suggested (cf. 8) that data about in vivo doses in humans should be combined with data from different test systems where the genotoxic effects of the alkylating agent in question and y-radiation can be compared. For such a combination of data a risk estimation was made for human exposure to EtO (29) . This estimation pointed to a risk of the same order of magnitude as that suggested by the epidemiological studies in Sweden previously mentioned. According to this risk estimate the exposure to -0.1 p.p.m., 40 h per week, amounts to a cancer risk of the same order as that considered acceptable for persons occupationally exposed to ionizing radiation.
